Moreover, B7H3-IL7R-S CAR-T cells demonstrated a significantly higher number of effector cells than did conventional B7H3 CAR-T cells after the fourth re-exposure to the GBM cells (Fig. 4d, g). The gene discussed is IL7R; the disease is glioblastoma.